Oxford University Investments

Oxford University has invested in 11 companies and its latest investment was OrganOx on Feb 23, 2025

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

OrganOx is an England-based medical device company that develops and manufactures automated normothermic machine perfusion systems for liver transplantation.
$142M
Feb 23, 2025
-
Diffblue is an England-based generative AI platform that offers solutions such as automated unit testing and application modernization for developers.
$6.3M
Oct 29, 2024
-
$9.8M
Sep 22, 2024
-
Oxford Endovascular is an England-based medical device company that manufactures and supplies flow-diverter stents for the treatment of neurovascular diseases.
$10.2M
May 19, 2024
-
Theolytics is an England-based biotechnology company that researches and distributes novel therapeutics for the treatment of cancer.
$24.5M
Apr 16, 2024
-

Frequently Asked Questions about Oxford University

  1. What is Oxford University investing in?

    Oxford University has invested in 11 companies including OrganOx, Diffblue and Fluorok
  2. What company did Oxford University invest in?

    Oxford University invested in a total 11 companies including OrganOx, Diffblue and Fluorok
  1. What are the top 5 investments by Oxford University?

    The top companies in which Oxford University invested are OrganOx, Diffblue, Fluorok, Oxford Endovascular and Theolytics